Additionally, the concentration of i.t. 4–1BBL was measured with Luminex and showed 45% increased levels in the tumor hemisphere of mice treated with AAVF-GFAP-Tnfsf9 compared with AAVF-GFAP-null (Figure 7F). This evidence concerns the gene GFAP and neoplasm.